Antigenics Inc ANTI:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 10/12/23 EDT
0.00UNCH (UNCH)
52 week range
0.00 - 0.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date10/12/23
  • 52 Week Low0.00
  • 52 Week Low Date05/08/23

Key Stats

  • Market Cap2,391.638
  • Shares Out341.66M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date10/12/23
  • 52 Week Low0.00
  • 52 Week Low Date05/08/23
  • Market Cap2,391.638
  • Shares Out341.66M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-14.039M
  • ROE (TTM)-316.03%
  • Revenue (TTM)1.86M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-766.88%
  • Debt To Equity (MRQ)-878.14%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Antigenics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Antigenics Inc., formerly Agenus Inc., is an immunotherapy company. The Company is developing a series of checkpoint modulators (CPM) for the treatment of patients with cancer, infectious diseases, and other immune disorders; heat shock protein (HSP)-based vaccines, and saponin-based vaccine adjuvants, principally QS-21 Stimulon adjuvant (QS-21 Stimulon). The Retrocyte Display (Retroviral B Lymphocyte Display) is an antibody discovery platform designed for the discovery and...
Address
700 Business Center Dr
Horsham, PA
19044
United States